Physician profile
Andrea Galloway
NPI 1942224225
$251,774.07
in general payments reported to CMS, 2019-2025
21 companies · $7,598 in 2025
The $7,598 reported for 2025 was more than what 94% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158K · 2020: $46K · 2021: $36K · 2022: $3,867 · 2023: $341 · 2024: $353 · 2025: $7,598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $2,209 · Food and Beverage: $1,583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $2,208.84 |
| Food and Beverage | $1,582.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $241,568.49 | 2019-2025 | |
| Intuitive Surgical, INC. | $7,353.29 | 2024-2025 | |
| Coloplast Corp | $1,466.56 | 2019-2025 | |
| Astellas Pharma US INC | $345.65 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $313.06 | 2023-2025 | Gemtesa, Myfembree |
| Urovant Sciences INC | $190.83 | 2021-2022 | |
| Allergan, INC. | $148.16 | 2019 | |
| Myovant Sciences INC. | $103.50 | 2021 | |
| Exeltis, USA INC. | $50.20 | 2025 | Slynd |
| Millicent US INC | $45.55 | 2023 | Femring, Intrarosa |
| Myriad Women'S Health, INC. | $41.20 | 2023 | Myrisk |
| Caldera Medical, INC | $29.95 | 2025 | |
| Richard Wolf Medical Instruments Corp. | $26.66 | 2025 | |
| Boston Scientific Corporation | $25.31 | 2025 | Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Exact Sciences Corporation | $20.79 | 2023 | Cologuard Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $16.88 | 2025 | |
| Amag Pharmaceuticals, INC. | $15.16 | 2019 | |
| Organon LLC | $12.83 | 2023 | Nexplanon |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Galloway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.